BioCentury | Jan 22, 2002
Financial News

Sonus raises $13.6 million

...with an exercise price of $9.40 per share. Investors included S.A.C. Capital; S.A.C. HealthCo Fund; Narragansett Asset Management...
BioCentury | Aug 30, 2001
Financial News

Hyseq raises $21.3 million

...share, which may be adjusted to $7.95 per share based on future issuances. Investors included Narragansett Asset Management...
BioCentury | Nov 13, 2000
Finance

Schroder's plans for IBT

...the ALT-711 advanced glycosylation end-product (A.G.E.) compound in cardiovascular disease. The investors, including S.A.C. Capital, Narragansett Asset Management...
Items per page:
1 - 3 of 3
BioCentury | Jan 22, 2002
Financial News

Sonus raises $13.6 million

...with an exercise price of $9.40 per share. Investors included S.A.C. Capital; S.A.C. HealthCo Fund; Narragansett Asset Management...
BioCentury | Aug 30, 2001
Financial News

Hyseq raises $21.3 million

...share, which may be adjusted to $7.95 per share based on future issuances. Investors included Narragansett Asset Management...
BioCentury | Nov 13, 2000
Finance

Schroder's plans for IBT

...the ALT-711 advanced glycosylation end-product (A.G.E.) compound in cardiovascular disease. The investors, including S.A.C. Capital, Narragansett Asset Management...
Items per page:
1 - 3 of 3